v3.26.1
Medical Expenses Payable
6 Months Ended
Jun. 30, 2026
Insurance [Abstract]  
Medical Expenses Payable Medical Expenses Payable
The following table is a detail of medical expenses payable as of June 30, 2026 and December 31, 2025:
 June 30,
2026
December 31,
2025
Claims incurred but not paid$269,790 $297,368 
Capitation and risk-sharing payable111,696 85,083 
Other231,262 92,118 
Medical expenses payable$612,748 $474,569 
Each period, we re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. As more complete claim information becomes available, we adjust the amount of the estimates and include the changes in estimates in claim costs in the period in which the change is identified. Substantially, all of the total claims paid by us are known and settled within the first year from the date of service, and substantially, all remaining claim amounts are paid within a three-year period.
The following table presents components of the change in medical expenses payable as of June 30, 2026 and 2025:
June 30,
2026
June 30,
2025
Claims incurred but not paid - beginning balance$297,368 $168,357 
Incurred related to:
Current year796,057 559,320 
Prior years(17,759)(21,066)
Total incurred, net of reinsurance778,298 538,254 
Payments related to:
Current year560,499 368,014 
Prior years245,377 127,134 
Total payments, net of reinsurance805,876 495,148 
Claims incurred but not paid - ending balance269,790 211,463 
Capitation payable, risk-sharing payable, and other342,958 243,691 
Total medical expenses payable$612,748 $455,154 
We re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. We recognized an unfavorable prior year development, excluding provision for adverse deviation of $6,532 for the three months ended June 30, 2026. The unfavorable prior year development was primarily due to worse-than-expected claims recoveries and actual claims expense being more than expected. We recognized a favorable prior year development, excluding provision for adverse deviation, of $1,847 for the six months ended June 30, 2026. The favorable prior year development was primarily due to better-than-expected claims recoveries and actual claims expense being less than expected.